Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry
✍ Scribed by Allan Weimann; Mads Sabroe; Henrik E. Poulsen
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 165 KB
- Volume
- 40
- Category
- Article
- ISSN
- 1076-5174
- DOI
- 10.1002/jms.785
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Analysis of caffeine and its metabolites is of interest with respect to caffeine exposure, for kinetic and metabolism studies and for opportunistic in vivo estimation of drug metabolizing enzyme activity in humans and animals. For the latter, analysis is usually done by high‐performance liquid chromatography (HPLC) with UV detection. However, this method is close to the detection limit for certain of the metabolites and requires very long chromatography, 30–60 min. We have developed a fast method for the quantification of caffeine and its metabolites 1‐methylxanthine, 1‐methyluric acid, 1,7‐dimethyluric acid, 5‐acetylamino‐6‐amino‐3‐methyluracil (AAMU) and 5‐acetylamino‐6‐formylamino‐3‐methyluracil (AFMU) by HPLC tandem mass spectrometry (MS/MS) in urine that requires only its dilution with buffer and centrifugation before injection into the HPLC/MS/MS system. The chromatography lasts 7 min and is followed by 4.5 min for re‐equilibration of the HPLC column, giving a total analysis time of 11.5 min. The method provides a great sensitivity improvement with detection limits for all analytes ≤25 nM in real samples. Also, the analysis provides much improvement in capacity to ∼125 samples per 24 h. Intra‐ and inter‐day coefficients of variation of a single analysis are <6.5% for all the analytes. The inter‐day coefficient of variation of duplicate analyses is <4.8% for all analytes. The method is automated, including automated integration, and it is fast, robust and suitable for large‐scale investigations in humans and animals. Copyright © 2005 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Cyadox is a novel antimicrobial growth‐promoter of the quinoxalines. For food safety and pharmacokinetic studies, a convenient, sensitive and reproducible LC‐ESI‐MS/MS method was developed for the simultaneous determination of cyadox and its major metabolites, quinoxaline‐2‐carboxylic a
9-Fluorenylmethyloxycarbonyl (FMOC) derivatives of catecholamines, including dopamine (DA; 3,4-dihydroxyphenethylamine), norepinephrine (NE; 2-amino-1-(3,4-dihydroxyphenyl)ethanol) and epinephrine (EPI; 1-phenyl-1-hydroxy-2-methylaminopropane) as well as 3, 4-dihydroxybenzylamine (DHBA) have been an
A sensitive, specific and accurate high performance liquid chromatography/ionspray-tandem mass spectrometry procedure (HPLC/MS/MS) has been developed to quantify cyclophosphamide in human urine from hospital personnel involved in drug preparation and administration of antineoplastic alkylating agent
A new specific HPLC-TSP-MS/MS assay for identification of b-blocking drug talinolol and its metabolites in urinary samples of man, dog, rat and mouse after single oral administration has been developed. Centrifuged udnes were directly injected into the HPLC-TSP-MS system. Based on thermospray MS/MS
A reversed-phase high-performance liquid chromatography-electrospray-tandem mass spectrometry assay (HPLC-ESI-MS/MS) was developed to quantitate cortisol, cortisone, 20 alpha- and beta-dihydrocortisol, 20 alpha- and beta-dihydrocortisone, tetrahydrocortisol, and tetrahydrocortisone. The technique wa